Australia markets closed
Explore/

Battling Cancer

Battling Cancer

7.33k followers18 symbols Watchlist by Motif Investing

Successful drug approvals by the FDA and innovations in the treatment of cancer could provide relevant stocks a boost.

Curated by Motif Investing

Background

Cancer is a leading cause of death worldwide, and the number of new cases is expected to rise by about 70 percent over the next two decades. In the U.S., more than half a million people die from cancer which claims one of every four deaths, making it the second leading cause of death after heart disease, according to Centers for Disease Control. As more cancer drugs are approved in the U.S. than anywhere else, it is no wonder that it also pays the highest bills for cancer drugs.

Having reached $100 billion in annual sales, the global market for cancer drugs could reach $147 billion by 2018. Meanwhile, the cost per month for a new cancer drug has jumped 40 percent to nearly $6,000, over the past decade. However you look at it, cancer drugs and innovations in the pipeline are creating significant opportunities in the pharmaceutical and biotech sectors.

How did we choose these stocks?

We identified US-listed stocks and American Depository Receipts of companies that are engaged in activities relevant to this watchlist's theme. We then filtered out companies that have a share price of less than $1.00 or a market capitalization less than $100 million, and excluded illiquid stocks by screening companies for liquidity i.e. average bid-ask spreads, dollar volume traded etc. Finally the proprietary Motif Optimization Engine determined the constituent stocks. Learn more about how we select our watchlists.

Who made these selections?

Motif is an online brokerage built on thematic portfolios of up to 30 stocks and ETFs. Founded in 2010 by Hardeep Walia, Motif combines complex proprietary algorithms with skilled advisers to develop these thematic portfolios. Learn more about our team.

How are these weighted?

First, we determined each company's percentage of total revenue derived from this watchlist's theme. Second, we applied a pure-play factor to give greater relative weight to companies that derive a higher percentage of their revenue from this theme. Finally, we weighted each company by its market capitalization adjusted for revenue exposure to the theme.

More details on how we build and weight watchlists are available here.

Performance

WatchlistChange today1-month return1-year returnTotal return
Battling Cancer-0.48%-6.60%-15.55%-36.41%
^GSPC+0.06%+5.22%+16.25%+3503.53%

18 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
BMYBristol-Myers Squibb Company61.02-0.31-0.51%4:00 pm GMT-49.97M14.13M137.53B
SGENSeattle Genetics, Inc.160.45-1.35-0.83%4:00 pm GMT-4727.65k1.20M27.92B
EXASExact Sciences Corporation86.69-3.71-4.10%4:00 pm GMT-41.55M1.37M13.02B
BPMCBlueprint Medicines Corporation74.45-0.18-0.24%4:00 pm GMT-4205.66k544.85k4.12B
FGENFibroGen, Inc.44.2+2.75+6.63%4:00 pm GMT-41.15M689.06k3.99B
INOInovio Pharmaceuticals, Inc.20.22-0.11-0.54%4:00 pm GMT-49.75M35.86M3.20B
MGNXMacroGenics, Inc.27.42-0.02-0.07%4:00 pm GMT-4516.05k1.45M1.48B
SPPISpectrum Pharmaceuticals, Inc.3.845-0.07-1.66%4:00 pm GMT-43.61M2.30M546.32M
GERNGeron Corporation1.68+0.02+1.20%4:00 pm GMT-42.98M4.01M521.42M
PGNXProgenics Pharmaceuticals, Inc.4.1-0.43-9.39%4:00 pm GMT-434.93M1.84M355.05M
ARAYAccuray Incorporated2.61+0.02+0.77%4:00 pm GMT-4353.17k612.53k236.25M
MACKMerrimack Pharmaceuticals, Inc.3.37+0.07+2.12%4:00 pm GMT-411.11k25.89k45.09M
FMIFoundation Medicine, Inc.---6:07 pm GMT-4---
INSYINSYS Therapeutics, Inc.0.2911--9:37 am GMT-4---
SCLN----6:07 pm GMT-4---
JUNO----6:07 pm GMT-4---
KITE----6:07 pm GMT-4---